Automated Endoscopy Reprocessor Market Overview
As per MRFR analysis, the Automated Endoscopy Reprocessor Market Size was estimated at 1.36 (USD Billion) in 2022. The Automated Endoscopy Reprocessor Market is expected to grow from 1.47 (USD Billion) in 2023 to 2.8 (USD Billion) by 2032. The Automated Endoscopy Reprocessor Market CAGR (growth rate) is expected to be around 7.45% during the forecast period (2024 - 2032).
Key Automated Endoscopy Reprocessor Market Trends Highlighted
The Automated Endoscopy Reprocessor Market is experiencing a surge in demand, driven primarily by the increasing prevalence of endoscopic procedures and the growing emphasis on infection prevention and control in healthcare settings.
The adoption of automated reprocessing systems enhances efficiency and streamlines workflow, freeing up healthcare professionals for more patient-focused tasks.
Moreover, technological advancements, such as the integration of artificial intelligence and data analytics, are transforming reprocessing processes, leading to improved accuracy and traceability.
The expanding geriatric population and the rising incidence of chronic diseases further contribute to the growing need for endoscopy procedures, driving market growth.
Additionally, government regulations and initiatives aimed at improving patient safety and reducing healthcare-associated infections are shaping the market landscape, emphasizing the critical role of automated endoscopy reprocessors in maintaining high standards of hygiene and infection control.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Endoscopy Reprocessor Market Drivers
Increasing Prevalence of Gastrointestinal Diseases
The increasing prevalence of gastrointestinal diseases across the globe is one of the major factors driving the Automated Endoscopy Reprocessor Market.
Gastrointestinal disorders, such as gastroesophageal reflux disease, inflammatory bowel disease, and colorectal cancer, have become common due to the growing consumption of unhealthy food, lack of exercise and aging population across the globe.
In order to cure and diagnose these ailments, a large number of endoscopic treatments need to be carried out, increasing the demand for AERs.
Technological Advancements and Innovation
The Automated Endoscopy Reprocessor Market is also driven by technological advancements and innovation. Manufacturers are continuously introducing new and improved AERs with enhanced features and capabilities.
These advancements include improvements in reprocessing efficiency, reduced cycle times, and increased automation.
Additionally, the integration of advanced technologies, such as artificial intelligence (AI) and data analytics, is enhancing the accuracy and efficiency of AERs.
Growing Emphasis on Infection Prevention and Control
Another driver of the Automated Endoscopy Reprocessor Market is the growing focus on infection prevention and control in healthcare facilities.
AERs are vital in this regard, as they eliminate the risk of infections caused by ineffective cleaning of endoscopes.
There are several guidelines and regulations that are supposed to be adhered to protect patients from the transmission of potentially harmful infections. The increased use of AERs is bound to ensure that these regulations are adhered to completely.
Automated Endoscopy Reprocessor Market Segment Insights
Automated Endoscopy Reprocessor Market Level of Automation Insights
The Automated Endoscopy Reprocessor Market is segmented based on the level of automation as fully automated, semi-automated, and manually assisted.
The fully automated segment held the largest share of the market in 2023, accounting for more than 45% of the revenue generated in the Automated Endoscopy Reprocessor Market.
The prominence of this segment is primarily due to the rapid adoption of advanced technologies and the increasing need for effective and efficient solutions for reprocessing in healthcare facilities.
Nevertheless, the semi-automated segment is likely to register the fastest growth over the forecast period because it is affordable and easy to implement in the context of the existing reprocessing workflow.
Finally, the manually assisted Automated Endoscopy Reprocessor Market segment is not the primary option for healthcare facilities because it is somewhat inconvenient and less effective.
However, the lower costs associated with this segment will guarantee its relevance and potential applicability for smaller institutions that cannot afford complex reprocessing devices or may not need them as frequently as large healthcare centers.
The Automated Endoscopy Reprocessor Market is likely to grow substantially over the next decade because the prevalence of gastrointestinal diseases is on the rise, and global health expenditures are increasing, facilitating broader adoption of advanced technology products.
The growth in demand for Automated Endoscopy Reprocessing devices is driven by the increasing awareness of effective reprocessing and control of infections, as well as the need to ensure the highest level of patient safety.
In addition, the increasing number of minimally invasive endoscopic treatments will create conditions for the development of a high demand for automated endoscopy reprocessor products.
Key players in the Automated Endoscopy Reprocessor Market are Getinge, Olympus, and Medtronic.
These companies are likely to intensify their focus on the development of new and highly advanced reprocessing technologies to cater to the increasingly complex and specific needs of all healthcare facilities.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Endoscopy Reprocessor Market Capacity Insights
The Automated Endoscopy Reprocessor Market is segmented by Capacity into Low Capacity (Up to 5 Endoscopes per Cycle), Medium Capacity (6-10 Endoscopes per Cycle), and High Capacity (11 Endoscopes or More per Cycle).
In 2023, the Medium Capacity segment held the largest market share, accounting for around 45% of the Automated Endoscopy Reprocessor Market revenue.
This is due to the increasing demand for efficient and cost-effective reprocessing solutions for endoscopes in hospitals and clinics.
The High-capacity segment is expected to witness significant growth in the coming years, owing to the rising number of surgical procedures and the growing adoption of automated reprocessing systems in large hospitals and healthcare facilities.
The Low-capacity segment is expected to hold a steady market share, catering to the needs of small clinics and ambulatory surgical centers.
Automated Endoscopy Reprocessor Market Type Insights
The Automated Endoscopy Reprocessor Market is segmented by type into standalone reprocessors and integrated systems (including endoscope washer-disinfectors).
Integrated systems include endoscope washer-disinfectors, which are automated systems that clean and disinfect endoscopes, and standalone reprocessors, which are separate units that perform the same functions.
The Automated Endoscopy Reprocessor Market was valued at USD 1.47 billion in 2023 and is expected to grow to USD 2.8 billion by 2032, at a CAGR of 7.45% over the forecast period.
The growth of the market is attributed to the increasing demand for endoscopy procedures, the rising prevalence of healthcare-associated infections, and the need for efficient and effective reprocessing of endoscopes.
Standalone reprocessors are expected to hold a larger market share during the forecast period due to their lower cost and ease of use. Integrated systems are expected to grow at a higher CAGR due to their increased efficiency and ability to handle a larger volume of endoscopes.
Automated Endoscopy Reprocessor Market Endoscope Type Insights
The Automated Endoscopy Reprocessor Market is segmented by Endoscope Type into Flexible Endoscopes and Rigid Endoscopes. Flexible endoscopes held the largest share of the market in 2023, and this trend is expected to continue during the forecast period.
The rising prevalence of gastrointestinal diseases, the increasing number of endoscopic procedures, and technological advancements in flexible endoscopes are driving the growth of this segment.
Rigid endoscopes, on the other hand, are expected to witness a steady growth rate during the forecast period due to their increasing use in minimally invasive surgeries and diagnostic procedures.
The Automated Endoscopy Reprocessor Market revenue for Flexible Endoscopes is projected to reach USD 1.2 billion by 2024, growing at a CAGR of 7.6%, while the market for Rigid Endoscopes is expected to reach USD 0.27 billion by 2024, growing at a CAGR of 6.9%.
These segments represent a significant growth opportunity for manufacturers and suppliers in the Automated Endoscopy Reprocessor Market.
Automated Endoscopy Reprocessor Market Application Insights
Hospitals, Ambulatory Surgical Centers, and Endoscopy Centers are the three primary applications for Automated Endoscopy Reprocessors globally. Hospitals dominate the market due to the high volume of endoscopic procedures performed in these settings.
This growth can be attributed to the increasing prevalence of gastrointestinal diseases, rising demand for minimally invasive procedures, and technological advancements in AERs.
Ambulatory Surgical Centers and Endoscopy Centers are also witnessing significant growth due to their convenience and cost-effectiveness compared to hospitals.
Automated Endoscopy Reprocessor Market Regional Insights
The regional segmentation of the Automated Endoscopy Reprocessor Market offers insights into the market's geographic distribution and growth potential.
North America is expected to hold a significant share of the market, driven by the presence of major healthcare facilities and a high adoption rate of advanced medical technologies.
Europe is another key region, with a well-established healthcare infrastructure and a growing demand for automated endoscopy reprocessors.
The APAC region is projected to witness the fastest growth, owing to the increasing healthcare expenditure and the rising prevalence of gastrointestinal diseases.
South America and MEA are expected to contribute a smaller share to the overall market, but they are also witnessing steady growth due to the expanding healthcare sector and government initiatives to improve healthcare access.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Endoscopy Reprocessor Market Key Players and Competitive Insights
Major players in the Automated Endoscopy Reprocessor Market are focused on expanding their product portfolio, either through internal development or acquisitions. For instance, in March 2021, Cantel Medical Corporation announced the acquisition of Nanosonics.
Similarly, in December 2020, STERIS Corporation announced the acquisition of Cantel Medical Corporation. These acquisitions have helped the companies strengthen their position in the Automated Endoscopy Reprocessor Market and offer a wider range of products to their customers.
Leading Automated Endoscopy Reprocessor Market players are also investing in research and development to introduce innovative products and technologies.
For instance, in January 2021, Getinge announced the launch of its new AER 4400 Automated Endoscope Reprocessor, which is designed to improve efficiency and reduce the risk of infection. Such developments are expected to drive the growth of the Automated Endoscopy Reprocessor Market in the coming years.
Stryker Corporation is a leading provider of medical technologies, including Automated Endoscopy Reprocessors. The company has a strong presence in the Automated Endoscopy Reprocessor Market with its AER product line.
Stryker's AERs are known for their reliability, efficiency, and user-friendliness. The company has a global sales and distribution network, which allows it to reach customers in all major markets. Stryker is committed to providing innovative products and services that help improve patient care.
The company invests heavily in research and development to ensure that its products are at the cutting edge of technology.
Medtronic is another major player in the Automated Endoscopy Reprocessor Market. The company's AERs are known for their high quality and performance. Medtronic has a strong focus on customer satisfaction and provides excellent technical support to its customers.
The company has a global sales and distribution network, which allows it to reach customers in all major markets.
Medtronic is committed to providing innovative products and services that help improve patient care. The company invests heavily in research and development to ensure that its products are at the cutting edge of technology.
Key Companies in the Automated Endoscopy Reprocessor Market Include
- Wassenburg Medical
- Karl Storz
- EndoChoice
- Medtronic
- MD Endoscope Service
- Stryker
- Aesculap
- Ecolab
- Steris
- Cantel Medical
- Morita
- Olympus
- BeaconMedaes
- Getinge
- Hoya
Automated Endoscopy Reprocessor Market Developments
The Automated Endoscopy Reprocessor (AER) market has been experiencing steady growth, driven by increasing demand for efficient and effective infection control measures in healthcare facilities.
Automated Endoscopy Reprocessor Market Segmentation Insights
Automated Endoscopy Reprocessor Market Level of Automation Outlook
- Fully Automated
- Semi-Automated
- Manually Assisted
Automated Endoscopy Reprocessor Market Capacity Outlook
- Low Capacity (Up to 5 Endoscopes per Cycle)
- Medium Capacity (6-10 Endoscopes per Cycle)
- High Capacity (11 Endoscopes or More per Cycle)
Automated Endoscopy Reprocessor Market Type Outlook
- Standalone Reprocessors
- Integrated Systems (Including Endoscope Washer-Disinfectors)
Automated Endoscopy Reprocessor Market Endoscope Type Outlook
- Flexible Endoscopes
- Rigid Endoscopes
Automated Endoscopy Reprocessor Market Application Outlook
- Hospitals
- Ambulatory Surgical Centers
- Endoscopy Centers
Automated Endoscopy Reprocessor Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
1.36(USD Billion) |
| Market Size 2023 |
1.47(USD Billion) |
| Market Size 2032 |
2.8(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
7.45% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Wassenburg Medical, Karl Storz, EndoChoice, Medtronic, MD Endoscope Service, Stryker, Aesculap, Ecolab, Steris, Cantel Medical, Morita, Olympus, BeaconMedaes, Getinge, Hoya |
| Segments Covered |
Level of Automation, Capacity, Type, Endoscope Type, Application, Regional |
| Key Market Opportunities |
Increasing prevalence of gastrointestinal disorders Growing demand for minimally invasive procedures Technological advancements in AERs Rising healthcare expenditure in emerging economies Expansion of healthcare facilities |
| Key Market Dynamics |
Increase in minimally invasive surgeries Advancements in technology Rise in healthcare-associated infections Growing geriatric population Government initiatives for healthcare infrastructure development |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Automated Endoscopy Reprocessor Market is expected to reach USD 2.8 billion by 2032, growing at a CAGR of 7.45% from 2024 to 2032.
North America is expected to hold the largest market share in the Automated Endoscopy Reprocessor Market throughout the forecast period.
The increasing prevalence of gastrointestinal diseases, growing demand for minimally invasive procedures, and stringent regulatory guidelines for infection control are driving the growth of the Automated Endoscopy Reprocessor Market.
Automated Endoscopy Reprocessors are primarily used in hospitals, clinics, and surgical centers for the reprocessing of endoscopes and other medical devices.
Some of the key competitors in the Automated Endoscopy Reprocessor Market include Getinge, Olympus, Medtronic, and STERIS.
The Automated Endoscopy Reprocessor Market is expected to grow at a CAGR of 7.45% from 2024 to 2032.
